AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 190 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $466,192 | -22.9% | 59,999 | -4.0% | 0.39% | -14.9% |
| Q2 2023 | $604,990 | -14.4% | 62,499 | -3.1% | 0.46% | -17.4% |
| Q1 2023 | $706,909 | +336.4% | 64,499 | +72.0% | 0.55% | +351.6% |
| Q4 2022 | $161,996 | -42.6% | 37,499 | 0.0% | 0.12% | -49.4% |
| Q3 2022 | $282,000 | -25.2% | 37,499 | 0.0% | 0.24% | -20.5% |
| Q2 2022 | $377,000 | -18.8% | 37,499 | 0.0% | 0.30% | -2.3% |
| Q1 2022 | $464,000 | -59.8% | 37,499 | -25.7% | 0.31% | -57.7% |
| Q4 2021 | $1,155,000 | +3.2% | 50,499 | -0.1% | 0.73% | -11.2% |
| Q3 2021 | $1,119,000 | +82.2% | 50,569 | +6.8% | 0.82% | +82.7% |
| Q2 2021 | $614,000 | +172.9% | 47,354 | +191.1% | 0.45% | +133.7% |
| Q4 2020 | $225,000 | -6.2% | 16,266 | 0.0% | 0.19% | -10.6% |
| Q3 2020 | $240,000 | -13.4% | 16,266 | -4.4% | 0.22% | -28.9% |
| Q2 2020 | $277,000 | +12.6% | 17,016 | 0.0% | 0.30% | +2.4% |
| Q1 2020 | $246,000 | -29.7% | 17,016 | -1.7% | 0.30% | -20.6% |
| Q4 2019 | $350,000 | – | 17,316 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |